Trial record 1 of 1 for:
F8394-201
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05503797 |
|
Recruitment Status :
Recruiting
First Posted : August 17, 2022
Last Update Posted : May 3, 2024
|
Sponsor:
Fore Biotherapeutics
Information provided by (Responsible Party):
Fore Biotherapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 27, 2025 |
| Estimated Study Completion Date : | August 28, 2026 |